Has FDG PET/CT an impact on the management of patients with anal carcinoma?

被引:1
|
作者
Vercellino, L. [1 ]
de Parades, V. [2 ]
Nataf, V. [1 ]
Kerrou, K. [1 ]
Huchet, V. [1 ]
Bauer, P. [2 ]
Pascal, O. [1 ]
Touboul, E. [3 ]
Montravers, F. [1 ]
Talbot, J. -N. [1 ]
机构
[1] Univ Paris 06, Hop Tenon, Nucl Med Serv, F-75020 Paris 20, France
[2] Grp Hosp Diaconesses Croix St Simon, Serv Proctol Med Interventionnelle, F-75012 Paris, France
[3] Univ Paris 06, Hop Tenon, Serv Oncol Radiotherapie, F-75020 Paris 20, France
关键词
Anal carcinoma; FDG; PET/CT; Impact on management; POSITRON-EMISSION-TOMOGRAPHY; EPIDERMOID CARCINOMA; CANCER; CT; F-18-FDG; SURVIVAL; TUMORS; HIV-1;
D O I
10.1016/j.mednuc.2009.12.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Purpose. To evaluate the impact of FDG PET/CT on the management of patients referred for the staging and/or the follow-up of anal carcinoma, and PET/CT on patient management. Patients and methods. We included patients referred to our department for anal carcinoma whose therapeutic management was evaluable thanks to follow-up data during at least 6 months. Results. Data of 44 patients were analysed: 22 had PET/CT for initial staging and 36 during follow-up. PET/CT had impact in nine patients out of 44 (20%) and it was relevant in eight of them. Conclusion. FDG PET/CT is an accurate imaging modality in anal cancer, its impact on patient management is more obvious when persistence or recurrence of disease is suspected. (C) 2009 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 50 条
  • [41] F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma
    Nguyen, Ba D.
    Ram, Panol C.
    Roarke, Michael C.
    CLINICAL NUCLEAR MEDICINE, 2007, 32 (03) : 234 - 236
  • [42] Posttreatment FDG-PET/CT Response Is Predictive of Tumor Progression and Survival in Anal Carcinoma
    Erickson, K. T.
    White, E. C.
    Rao, A. R.
    Kaptein, J. S.
    Lien, W. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S189 - S190
  • [43] Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
    Ahmet Bilici
    Bala Basak Oven Ustaalioglu
    Mesut Seker
    Nesrin Canpolat
    Bulent Tekinsoy
    Taflan Salepci
    Mahmut Gumus
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1259 - 1269
  • [44] Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma
    Goldman, Kelly E.
    White, Evan C.
    Rao, Aroor R.
    Kaptein, John S.
    Lien, Winston W.
    PRACTICAL RADIATION ONCOLOGY, 2016, 6 (05) : E149 - E154
  • [45] Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
    Bilici, Ahmet
    Ustaalioglu, Bala Basak Oven
    Seker, Mesut
    Canpolat, Nesrin
    Tekinsoy, Bulent
    Salepci, Taflan
    Gumus, Mahmut
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1259 - 1269
  • [46] Role of FDG PET/CT in Management of Patients with Prostate Cancer
    Sutherland, Duncan E. K.
    Azad, Arun A.
    Murphy, Declan G.
    Eapen, Renu S.
    Kostos, Louise
    Hofman, Michael S.
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 4 - 13
  • [47] The Clinical Impact of 18F-FDG PET/CT on Management of Patients with Lung Cancer
    Zsiray, M.
    Markoczy, Z.
    Magyar, M.
    Lengyel, Z.
    Szakall, S.
    Fekeshazy, A.
    Kasler, M.
    Borbely, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S332 - S333
  • [48] Impact of F-18 FDG PET/CT on management in head and neck cancer patients
    Tam, H. H.
    Patel, N.
    Sandhu, R.
    Win, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S250 - S250
  • [49] FDG PET/CT in the management of patients with fever of unknown origin
    Sollini, M.
    Froio, A.
    Fraternali, A.
    Di Paolo, M. L.
    Filice, A.
    Roncali, M.
    Casali, M.
    Pazzola, G.
    Muratore, F.
    Erba, P. A.
    Versari, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S138 - S138
  • [50] The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer
    Subedi, N.
    Scarsbrook, A.
    Darby, M.
    Korde, K.
    Mc Shane, P.
    Muers, M. F.
    LUNG CANCER, 2009, 64 (03) : 301 - 307